Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices 78091 

OMB Number: 3064–0115. 

Affected Public: Insured financial 

institutions. 

Estimated Burden Hours: 

Number of reports submitted: 50. 

Hours to prepare the report: 4 hours. 

Total annual burden hours 200 hours. 

General Description of Collection: The 

Prompt Corrective Action (‘‘PCA’’) 

provisions of section 38 of the Federal 

Deposit Insurance Act require or permit 

the FDIC and other federal banking 

agencies to take certain supervisory 

actions when FDIC-insured institutions 

fall within one of five capital categories. 

They also restrict or prohibit certain 

activities and require the submission of 

a capital restoration plan when an 

insured institution becomes 

undercapitalized. Various provisions of 

the statute and the FDIC’s implementing 

regulations require the prior approval of 

the FDIC before an FDIC-supervised 

institution can engage in certain 

activities, or allow the FDIC to make 

exceptions to restrictions that would 

otherwise be imposed. This collection of 

information consists of the applications 

that are required to obtain the FDIC’s 

prior approval. 

Request for Comment 

Comments are invited on: (a) Whether 

the collections of information are 

necessary for the proper performance of 

the FDIC’s functions, including whether 

the information has practical utility; (b) 

the accuracy of the estimates of the 

burden of the information collections, 

including the validity of the 

methodology and assumptions used; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the information collections on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

All comments will become a matter of 

public record. 

Dated at Washington, DC, this 22nd day of 

December, 2014. 

Federal Deposit Insurance Corporation. 

Robert E. Feldman, 

Executive Secretary. 

[FR Doc. 2014–30333 Filed 12–24–14; 8:45 am] 

BILLING CODE 6714–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Nominations for 

Membership on the Secretary’s 

Advisory Committee on Human 

Research Protections 

AGENCY: Office for Human Research 

Protections, Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

AUTHORITY: 42 U.S.C. 217a, section 222 

of the Public Health Service Act, as amended. 

The Committee is governed by the provisions 

of Public Law 92–463, as amended (5 U.S.C. 

Appendix 2), which sets forth standards for 

the formation and use of advisory 

committees. 

SUMMARY: The Office for Human 

Research Protections (OHRP), a program 

office in the Office of the Assistant 

Secretary for Health, Department of 

Health and Human Services (HHS), is 

seeking nominations of qualified 

candidates to be considered for 

appointment as members of the 

Secretary’s Advisory Committee on 

Human Research Protections (SACHRP). 

SACHRP provides advice and 

recommendations to the Secretary, HHS, 

through the Assistant Secretary for 

Health on matters pertaining to the 

continuance and improvement of 

functions within the authority of HHS 

directed toward protections for human 

subjects in research. SACHRP was 

established by the Secretary, HHS, on 

October 1, 2002. OHRP is seeking 

nominations of qualified candidates to 

fill two positions on the Committee 

membership that will be vacated during 

the 2015 calendar year. Previous 

nominees may be considered for the 

upcoming vacancies. 

DATES: Nominations for membership on 

the Committee must be received no later 

than February 12, 2015. 

ADDRESSES: Nominations should be 

mailed or delivered to Julia Gorey, 

Executive Director, SACHRP, Office for 

Human Research Protections, 

Department of Health and Human 

Services, 1101 Wootton Parkway, Suite 

200; Rockville, MD 20852. Nominations 

will not be accepted by email or by 

facsimile. 

FOR FURTHER INFORMATION CONTACT: Julia 

Gorey, Executive Director, SACHRP, 

Office for Human Research Protections, 

1101 Wootton Parkway, Suite 200, 

Rockville, MD 20852, telephone: (240) 

453–8141. A copy of the Committee 

charter and list of the current members 

can be obtained by contacting Ms. 

Gorey, accessing the SACHRP Web site 

at www.hhs.gov/ohrp/sachrp, or 

requesting via email at sachrp@

osophs.dhhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Committee provides advice on matters 

pertaining to the continuance and 

improvement of functions within the 

authority of HHS directed toward 

protections for human subjects in 

research. Specifically, the Committee 

provides advice relating to the 

responsible conduct of research 

involving human subjects with 

particular emphasis on special 

populations such as neonates and 

children, prisoners, the decisionally 

impaired, pregnant women, embryos 

and fetuses, individuals and 

populations in international studies, 

populations in which there are 

individually identifiable samples, data 

or information; and investigator 

conflicts of interest. 

In addition, the Committee is 

responsible for reviewing selected 

ongoing work and planned activities of 

the OHRP and other offices/agencies 

within HHS responsible for human 

subjects protection. These evaluations 

may include, but are not limited to, a 

review of assurance systems, the 

application of minimal research risk 

standards, the granting of waivers, 

education programs sponsored by 

OHRP, and the ongoing monitoring and 

oversight of institutional review boards 

(IRBs) and the institutions that sponsor 

research. 

Nominations: The OHRP is requesting 

nominations to fill two positions for 

voting members of SACHRP which will 

become vacant in July 2015. 

Nominations of potential candidates for 

consideration are being sought from a 

wide array of fields, including, but not 

limited to: Public health and medicine, 

behavioral and social sciences, health 

administration, and biomedical ethics. 

To qualify for consideration of 

appointment to the Committee, an 

individual must possess demonstrated 

experience and expertise in any of the 

several disciplines and fields pertinent 

to human subjects protection and/or 

clinical research. 

The individuals selected for 

appointment to the Committee can be 

invited to serve a term of up to four 

years. Committee members receive a 

stipend and reimbursement for per diem 

and any travel expenses incurred for 

attending Committee meetings and/or 

conducting other business in the 

interest of the Committee. Interested 

applicants may self-nominate. 

Nominations may be retained and 

considered for future vacancies. 

Nominations should be typewritten. 

The following information should be 

included in the package of material 

submitted for each individual being 

nominated for consideration: (1) A letter 

of nomination that clearly states the 

name and affiliation of the nominee, the 

basis for the nomination (i.e., specific 

attributes which qualify the nominee for 

service in this capacity), and a statement 

that the nominee is willing to serve as 


tkelley on DSK3SPTVN1PROD with NOTICES
78092 Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices 

a member of the Committee; (2) the 

nominator’s name, address, daytime 

telephone number, and the home and/ 

or work address, telephone number, and 

email address of the individual being 

nominated; and (3) a current copy of the 

nominee’s curriculum vitae. Federal 

employees should not be nominated for 

consideration of appointment to this 

Committee. 

The Department makes every effort to 

ensure that the membership of HHS 

Federal advisory committees is fairly 

balanced in terms of points of view 

represented and the committee’s 

function. Every effort is made to ensure 

that individuals from a broad 

representation of geographic areas, 

women and men, ethnic and minority 

groups, and the disabled are given 

consideration for membership on HHS 

Federal advisory committees. 

Appointment to this Committee shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, disability, and 

cultural, religious, or socioeconomic 

status. 

Individuals who are selected to be 

considered for appointment will be 

required to provide detailed information 

regarding their financial holdings, 

consultancies, and research grants or 

contracts. Disclosure of this information 

is necessary in order to determine if the 

selected candidate is involved in any 

activity that may pose a potential 

conflict with the official duties to be 

performed as a member of SACHRP. 

Dated: December 22, 2014. 

Jerry Menikoff, 

Director, Office for Human Research 

Protections, Executive Secretary, Secretary’s 

Advisory Committee, on Human Research 

Protections. 

[FR Doc. 2014–30400 Filed 12–24–14; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Request for Information 

AGENCY: Office of Child Support 

Enforcement (OCSE), Administration for 

Children and Families, HHS. 

ACTION: Notice of request for 

information. 

SUMMARY: The Administration for 

Children and Families (ACF) published 

a notice in the Federal Register on 

October 23, 2014, (79 FR 63406) 

requesting public comments to inform 

its upcoming Report to Congress. The 

Report to Congress is required to be 

submitted no later than June 30, 2015, 

under title III, section 305 of H.R. 4980 

(Pub. L. 113–183), Preventing Sex 

Trafficking and Strengthening Families 

Act of 2014. ACF stated in the notice 

that the request for information would 

remain open until December 22, 2014, 

for the receipt of public comments. To 

provide the public with more time to 

comment, ACF extends the period of 

time for which the comments will 

remain open. 

To provide clarification on the first 

bullet point under the Background 

Section, which was truncated in the first 

Federal Register Notice, please consider 

the following: A review of the 

effectiveness of state child support 

programs and collection practices and 

an analysis of the extent to which the 

practices result in unintended 

consequences or performance issues. 

DATES: Comments must be received by 

11:59 p.m. on February 27, 2015, to be 

considered. 

FOR FURTHER INFORMATION CONTACT: The 

Office of Child Support Enforcement at 

OCSEreport@acf.hhs.gov. 

Dated: December 19, 2014. 

Donna Bonar, 

Deputy Comissioner, Office of Child Support 

Enforcement. 

[FR Doc. 2014–30285 Filed 12–24–14; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–2214] 

Next Generation Sequencing 

Diagnostic Tests; Public Workshop; 

Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

following public workshop entitled 

‘‘Optimizing FDA’s Regulatory 

Oversight of Next Generation 

Sequencing Diagnostic Tests.’’ The 

purpose of this workshop is to discuss 

and receive feedback from the 

community on the questions in the 

discussion paper on diagnostic tests for 

human genetics or genomics using next 

generation sequencing (NGS) 

technology. 

DATES: The public workshop will be 

held on February 20, 2015, from 8:30 

a.m. to 5 p.m. 

ADDRESSES: The public workshop will 

be held at the Natcher Center at the 

National Institutes of Health Campus, 

9000 Rockville Pike, Bldg. 45 

Auditorium, Bethesda, MD 20814. For 

parking and security information, please 

refer to http://www.nih.gov/about/

visitor/. 

FOR FURTHER INFORMATION CONTACT: 

David Litwack, Office of In Vitro 

Diagnostics and Radiological Health, 

Center for Devices and Radiological 

Health, Food and Drug Administration, 

Bldg. 66, Rm. 5544, 10903 New 

Hampshire Ave., Silver Spring, MD 

20993, 301–796–6697, email: 

ernest.litwack@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Registration: Registration is free and 

available on a first-come, first-served 

basis. Persons interested in attending 

this public workshop must register 

online by 4 p.m. February 12, 2015. 

Early registration is recommended 

because facilities are limited and, 

therefore, FDA may limit the number of 

participants from each organization. If 

time and space permits, onsite 

registration on the day of the public 

workshop will be provided beginning at 

7:30 a.m. 

If you need special accommodations 

due to a disability, please contact Susan 

Monahan, 301–796–5661, email: 

Susan.Monahan@fda.hhs.gov no later 

than February 6, 2015. 

To register for the public workshop, 

please visit FDA’s Medical Devices 

News & Events—Workshops & 

Conferences calendar at http://

www.fda.gov/MedicalDevices/

NewsEvents/WorkshopsConferences/

default.htm. (Select this public 

workshop from the posted events list.) 

Please provide complete contact 

information for each attendee, including 

name, title, affiliation, address, email, 

and telephone number. If you are unable 

to register online, please contact Susan 

Monahan (see Registration.) Registrants 

will receive confirmation after they have 

been accepted. You will be notified if 

you are on a waiting list. 

Streaming Webcast of the Public 

Workshop: This public workshop will 

also be Webcast. Persons interested in 

viewing the Webcast must register 

online by February 12, 2015. Early 

registration is recommended because 

Webcast connections are limited. 

Organizations are requested to register 

all participants, but to view using one 

connection per location. Webcast 

participants will be sent technical 

system requirements after registration 

and will be sent connection access 

information after February 13, 2015. If 

you have never attended a Connect Pro 


tkelley on DSK3SPTVN1PROD with NOTICES